It is also important to note that some people may have trouble losing weight because of hormone problems, not always that the hormone problems are a result of weight, said Dr
Improve of digestive function Protection and promotion of healing of liver due to toxic stress
Peptides 112 , 125132 (2019)
The STEP 1 trial showed semaglutide 2.4 mg led to 14.9% weight loss over 68 weeks, while SURMOUNT-1 showed tirzepatide achieved up to 20.9% weight reductionapproaching bariatric surgery outcomes.[6] The SELECT trial (17,604 patients) found semaglutide reduced cardiovascular death, non-fatal heart attack, and non-fatal stroke by 20% and all-cause mortality by 19%, suggesting direct cardioprotective effects beyond weight loss.[4] In STEP-HFpEF, semaglutide produced 13.3% weight loss in heart failure patients and improved symptoms and physical function
Other improvements in surrogate endpoints included a reduction in decline of estimated glomerular filtration rate (eGFR), calculated by slope analysis (14)
This convenience boosts adherencea key factor in long-term diabetes control
